In a more complex trade I would want to be long some sort of ratio risk reversal.
Chart patterns suggest food delivery service company has bottomed out and may be turning.
But with indicators mixed, traders could approach the long side of GIS if they use a sell stop below $51.
Despite the financial positivity, many analysts warn the deal could have hiccups ahead.
The deal makes sense for growth - and for Allergan shareholders - but now the price and uncertainty make this stock hard to swallow.
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
Let's look at their price charts and technical indicators, and draw some conclusions.
Meanwhile, the latest economic data suggest the likelihood of a Fed rate cut at the next FOMC meeting.
Shares of the food giant may not have made a bottom, but it will be interesting to see how the stock behaves from here.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.